je.st
news
Tag: cholesterol
Alnylam, Medicines cholesterol drug lasts months after one shot
2015-08-30 11:16:29| Biotech - Topix.net
LONDON: A new drug in early development cuts cholesterol as much as two potent injections recently cleared for sale but lasts much longer, meaning it may need to be given only every three to six months, initial findings suggest. Results with Alnylam Pharmaceuticals and Medicines Co's experimental product ALN-PCSsc highlight the competition for a market tipped to generate billions of dollars in sales.
Tags: months
drug
shot
cholesterol
Amgen wins approval for second biotech cholesterol drug
2015-08-28 00:23:50| Biotech - Topix.net
" Amgen Inc. has won approval for the second medicine in a new class of biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades. The drug Repatha could eventually help millions of Americans who face increased risks of heart disease because they cannot control their cholesterol with existing drugs.
Tags: drug
approval
wins
biotech
Express Scripts says costly new cholesterol drugs could wreak havoc...
2015-07-29 20:28:22| Biotech - Topix.net
Express Scripts Holding Co., the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent new cholesterol drugs called PCSK9 inhibitors could "wreak financial havoc" among its clients. U.S. regulators on Friday approved the first of the new medicines, Praluent from Regeneron Pharmaceuticals Inc. and Sanofi SA.
Tags: express
drugs
scripts
costly
The high price of lower cholesterol
2015-07-27 19:29:55| Biotech - Topix.net
A new type of drug to lower LDL or "bad" cholesterol won approval from the U.S. Food and Drug Administration on Friday. The drug, called Praluent, from Sanofi and Regeneron Pharmaceuticals Inc., is considered the first major advance in cholesterol treatment since statins were first introduced more than 20 years ago.
Tags: price
high
lower
cholesterol
Sanofi's big new cholesterol drug wins European green light
2015-07-25 13:43:00| Biotech - Topix.net
A new type of cholesterol drug from Sanofi and Regeneron Pharmaceuticals won a green light from European regulators on Friday, two months behind a rival product from Amgen. The European Medicines Agency said its experts had recommended Praluent for patients unable to control their cholesterol despite taking optimal doses of conventional statin pills or those who cannot take statins.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »